Stanford University and University of Wisconsin–Madison researchers have developed a new device to achieve upconversion (UC) of incoherent near-infrared (NIR) photons beyond 1100nm to visible photons, through sensitized triplet–triplet annihilation (TTA).
Hydrogen that is free of greenhouse gas (GHG) emissions is a key vector to fuel a net-zero emissions economy, but today's H2 is sourced from fossil fuels mostly by the highly emissions-intensive processes of steam methane reforming (SMR) or coal gasification.
Overweight and obesity are linked to an increased risk and worsened outcome from many cancers, including colorectal, pancreatic and breast cancer, but the mechanisms responsible for these phenomena are unknown.
Stanford researchers have developed a novel methodology for the high-throughput expression and kinetic characterization of numerous enzyme variants in parallel using microfluidic droplet arrays.
Scientists in the Carette Lab at Stanford have developed AAV-Titer cell lines that enable (1) improved and standardized in vitro potency assays (2) determination of a functional titer of AAV vectors of different serotypes and containing different promotors.
Stanford researchers have defined subgroups of regulatory T cell (Tregs), CD39+ and CD39-, that can be genetically engineered to produce enhanced or reduced cytotoxicity without affecting their ability to suppress the immune system.
Stanford researchers have developed an innovative AI-driven solution that leverages the BERT-based AI model to automatically classify patient-provider messages into 12 distinct categories, reducing clinician workload and enhancing workflow efficiency in healthcare settings.
The recognition of peptide-MHC (pMHC) complexes by T cells is the cornerstone of cellular immunity, enabling the elimination of infected or tumoral cells. pMHC can thus be leveraged as a detection tool for T cells.
Stanford researchers have developed a 3D-printed biodegradable zinc implant with mechanical properties suitable for structural support after core decompression in osteonecrosis patients.
Researchers at Stanford University have discovered a first-in-class covalent inhibitor that binds to activated Fis1 and prevents mitochondrial fission and dysfunction.
Researchers at Stanford have developed a computational tool that enables the discovery of regenerative cells across all tissue types and novel targets in cancer.
Stanford researchers have designed a new type of reactor that uses magnetic induction instead of fossil fuel combustion to enable even distribution of high-grade heat for thermochemical processing.
Stanford researchers have developed an innovative ureteral stent (UreStent) which is designed to reduce stent-related complications by incorporating a distal tip with collapsible tube and a flexible retention cone to prevent urine reflux and bladder irritation, ensuring optima
Stanford researchers have developed tissue-based profiling by deep sequencing for detection of Minimal Residual Disease (MRD) by tracking patient-specific tumor mutations in post-chemotherapy tissue samples, enabling a highly sensitive, molecular-level assessment of residual c